News Daily News NOACs Significantly Curb Risk of VTE in Cancer Patients L.A. McKeown December 06, 2018
News Daily News Higher Rates of Amputation and Ketoacidosis With SGLT2 Inhibitors: European Registry Data Michael O'Riordan November 26, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2018 Shelley Wood October 31, 2018
News Daily News More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery L.A. McKeown October 18, 2018
News Conference News TCT 2018 Denervation Has Possible Benefit for Pulmonary Hypertension Related to Left Heart Failure Todd Neale September 23, 2018
News Conference News ESC 2018 My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More Shelley Wood September 14, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2018 Caitlin E. Cox September 04, 2018
News Conference News ESC 2018 Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD Todd Neale August 31, 2018
Presentation ESC 2018 Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results Presenter: Alex C. Spyropoulos August 27, 2018
News Conference News ESC 2018 MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis Todd Neale August 26, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Daily News European Regulators Nix Portola’s Factor Xa Inhibitor Betrixaban Todd Neale March 23, 2018
News Daily News Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II Michael O'Riordan February 21, 2018
News Daily News Migraine Associated With Broad Range of CVD Diagnoses in Nationwide Study Shelley Wood February 01, 2018